Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia

Published:2017-05-30 Issue:8 Volume:72 Page:2359-2367
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Cornely Oliver A.¹,Leguay Thibaut²,Maertens Johan³,Vehreschild Maria J. G. T.⁴,Anagnostopoulos Achilles⁵,Castagnola Carlo⁶,Verga Luisa⁷,Rieger Christina⁸,Kondakci Mustafa⁹,Härter Georg¹⁰,Duarte Rafael F.¹¹,Allione Bernardino¹²,Cordonnier Catherine¹³,Heussel Claus Peter¹⁴,Morrissey C. Orla¹⁵,Agrawal Samir G.¹⁶,Donnelly J. Peter¹⁷,Bresnik Mark¹⁸,Hawkins Michael J.¹⁸,Garner Will¹⁸,Gökbuget Nicola¹⁹,

Affiliation:

1. Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Department I of Internal Medicine, Clinical Trials Centre Cologne (ZKS), Center for Integrated Oncology (CIO KölnBonn), German Centre for Infection Research (DZIF), partner site Bonn-Cologne, University of Cologne, Cologne, Germany

2. Service d'hématologie clinique et Thérapie cellulaire, Hôpital du Haut-Lévèque, CHU de Bordeaux, France

3. KU Leuven-University of Leuven, Department of Microbiology and Immunology, University Hospitals Leuven, Department of Hematology, B-3000 Leuven, Belgium

4. Department I of Internal Medicine, University of Cologne, Cologne, Germany

5. Haematology Department – BMT Unit, George Papanicolaou Hospital, Thessaloniki 57010, Greece

6. Department of Hematology Oncology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy

7. Ospedale San Gerardo, Monza, Italy

8. Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Munich, Germany

9. Klinik für Hämatologie, Onkologie und klin. Immunologie, Universitätsklinikum Düsseldorf, Düsseldorf, Germany

10. Zentrum für Hormon- und Stoffwechselerkrankungen und Infektiologie, MVZ Endokrinologikum Ulm, and Department of Internal Medicine III, Ulm University Hospital Medical Center, Ulm, Germany

11. Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid 28222, Spain

12. Hematology, Ospedale S. Giovanni Battista Molinette, Torino, Italy

13. AP-HP-Henri Mondor, Hematology Department and University Paris-Est Creteil, F-94010 Créteil, France

14. Thoraxklinik, Universitätsklinikum Heidelberg, Heidelberg, Germany

15. Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Australia

16. Division of Haemato-Oncology, St Bartholomew's Hospital, Barts Cancer Institute, Queen Mary University, London, UK

17. Department of Haematology, Radboud UMC, Nijmegen, the Netherlands

18. Gilead Sciences, Foster City, CA, USA

19. Department of Medicine II, University Hospital, Goethe University, Frankfurt, Germany

Funder

NIH

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/72/8/2359/24332256/dkx133.pdf

Reference27 articles.

1. Modern therapy of acute lymphoblastic leukemia;Bassan;J Clin Oncol,2011

2. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study;Pagano;Haematologica,2006

3. Epidemiology of invasive fungal disease in lymphoproliferative disorders;Teng;Haematologica,2015

4. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group;de Pauw;Clin Infect Dis,2008

5. Patients at high risk of invasive fungal infections: when and how to treat;Rüping;Drugs,2008

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG;Blood;2023-12-07

2. A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation;Expert Review of Hematology;2023-12-02

3. Antifungal prophylaxis and pre-emptive therapy: When and how?;Molecular Aspects of Medicine;2023-08

4. Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia;Current Fungal Infection Reports;2023-07-27

5. Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO);Journal of Antimicrobial Chemotherapy;2023-06-13